Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's syndrome screening

The efficiency of a screening programme for Down's syndrome is usually expressed in terms of the detection rate for a given false positive rate. Two programmes with approximately equal detection rates and false positive rates would then be regarded as being broadly equivalent. While this might be the case at a population level, we show in this paper that it may be far from true at the individual patient level. Different algorithms, or even different implementations of the same algorithm can lead to calculation of very different individual risks and can result in different decisions for individual patients. Even though two programmes might lead to the same number of referrals, they could be referring quite different women. We consider the effect of using different parameter values within an algorithm, different algorithms and alternative ways of estimating the gestational age-dependent medians of the marker values. We show that the combined effects of these factors could explain much of the range of risks reported in the UK National External Quality Assessment Scheme for Down's syndrome screening.

[1]  F. Dunstan,et al.  Correlation of Marker Values in Down's Syndrome Screening: The Effect of Dating Error , 1999, Annals of clinical biochemistry.

[2]  H. Cuckle,et al.  Antenatal screening for Down's syndrome. , 1992, BMJ.

[3]  K. Spencer,et al.  Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical Markers , 1992, Annals of clinical biochemistry.

[4]  T. Reynolds,et al.  Ultrasonographic dating of pregnancy causes significant errors in Down syndrome risk assessment that may be minimized by use of biparietal diameter-based means. , 1992, American journal of obstetrics and gynecology.

[5]  H. Cuckle,et al.  Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight , 1992, British journal of obstetrics and gynaecology.

[6]  J. Connor,et al.  Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and age , 1991, Prenatal diagnosis.

[7]  J. Canick,et al.  Maternal serum screening for aneuploid pregnancy by alphafetoprotein, hCG, and unconjugated estriol , 1990, Obstetrics and gynecology.

[8]  N J Wald,et al.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphafetoprotein level , 1988, British journal of obstetrics and gynaecology.

[9]  H. Cuckle,et al.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level , 1987, British journal of obstetrics and gynaecology.